Despite the constant success of the health monitoring applications developed by Apple, in the diagnosis of cardiovascular diseases, since Cupertino think that there is still much to do. Therefore, this week the company has announced a new alliance with Johnson & Johnson for the development of a medical study that addresses this type of ailment.
Specifically, the new three-year study aims to gather more information on atrial fibrillation and other conditions tracked by iPhone and Apple Watch. Presented as the “Heartline Study” , the research will include an iPhone application and explore whether the health monitoring features of the iPhone and the heart health features in Apple Watch can improve health outcomes in people over 65.
This time, Apple and Johnson & Johnson are looking to see if Apple’s health monitoring technology can help reduce the risk of stroke by detecting atrial fibrillation early, which is a major cause of stroke but often difficult to diagnose due to the lack of physical symptoms in most patients.
According to Myoung Cha, Apple’s Head of Strategic Health Initiatives , Apple’s technology is having a significant impact on scientific research:
The study will have as research subjects people aged 65 or older residing in the United States. They must have traditional Medicare, have an iPhone 6s or later (with iOS 12.2 or later), and agree to provide access to their Medicare claims data. Once selected, they will be divided into two groups; one to test the apps on iPhone and the other on Apple Watch.